A

8 Announcements and Top Research You May Have Missed

by

8 Announcements. This article was sent to members via email March 27. By Brian Nelson, CFA Hi everyone, Brian here. Trust you are doing great! Here are eight announcements I want you to be aware of: Everything we do is for our members. We’re very proud of the outperformance of the Best Ideas Newsletter portfolio, that we’ve never had a dividend cut in the Dividend Growth Newsletter portfolio, that our high-yield ideas are holding up very well, and the success rates of the Exclusive capital-appreciation ideas and short-idea considerations are running at approximately 80%. We’re proud to be your research partner. The odds of a Fed rate cut are going up as yield-curve inversion continues to threaten. The risks are more behavioral in … Read more

Dividend Increases/Decreases for the Week November 19

by

Below we provide a list of firms that raised their dividends during the week ending November 19. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week 360 DigiTech (QFIN): now $0.14 per share quarterly dividend. AFLAC (AFL): now $0.40 per share quarterly dividend, was $0.33. Agilent Technologies (A): now $0.21 per share quarterly dividend, was $0.194. American National Bankshares (AMNB): now $0.28 per share quarterly dividend, was $0.27. Amkor Technology (AMKR): now $0.05 per share quarterly dividend, was $0.04. AMMO 8.75% PFD SER A (POWWP): now $1.0148 per share dividend, was $0.2412. … Read more

VIDEO/TRANSCRIPT: 2021 Valuentum Exclusive Call: Inflation Is Good

by

Valuentum’s President Brian Michael Nelson, CFA, explains why investors should not fear inflation, why government agencies such as the Fed and Treasury are prioritizing something other than price discovery, why the 10-year Treasury rate is a must-watch metric, and why Valuentum prefers the moaty constituents in large cap growth due to their net cash rich balance sheets, tremendous free cash flow generating potential, and secular growth tailwinds. Transcript: << Valuentum’s Best Ideas On behalf of the Valuentum team, I’d like to present to you our prepared remarks for the Valuentum Exclusive conference call for 2021. It is both an honor and a privilege to share our team’s work with you, and I personally am very grateful for your continued interest … Read more

Top Research and Ideas You May Have Missed

by

Is Quant Value Giving Intrinsic Value Investors a Bad Name? Surely, you don’t believe Warren Buffett’s “style” is out of favor? By Brian Nelson, CFA I need to make sure that you’re aware of something very important. The media and perhaps many investment professionals define the concept of “value” as companies with low price-to-book (P/B) ratios, and the concept of “growth” as companies with high price-to-book ratios. This definition of “value” and “growth” and their corresponding returns have been magnified in writings throughout the media and across quantitative research, even in prestigious journals. Warren Buffett has been rallying against most quantitative applications and how “growth” and “value” are defined in popular media and quantitative research for decades.  Here’s one of the Oracle’s most … Read more

2,350-2,750 on the S&P? Could the Coronavirus Catalyze a Financial Crisis?

by

Image: We think a rather modest sell-off in the market to the target range of 2,350-2,750 on the S&P 500 is rather reasonable in the wake of one of the biggest economic shocks since the Global Financial Crisis. The chart above shows how far markets have advanced since 2011, and an adjustment lower to the target range of 2,350-2,750 is rather modest in such a context and would only bring markets to late 2018 levels (note red box as the target range). The range reflects ~16x S&P 500 12-month forward earnings estimates, as of February 14, adjusted down 10% due to COVID-19. When companies like Visa talk about a couple percentage points taken off of growth rates, one knows that … Read more

Dividend Increases/Decreases for the Week of November 17

by

Below we provide a list of firms that raised their dividends during the week ending November 17. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week                          AECOM (ACM): now $0.22 per share quarterly dividend, was $0.18. Agilent Technologies (A): now $0.236 per share quarterly dividend, was $0.225. Alibaba (BABA): now $1.00/ADS annual dividend. Amkor Technology (AMKR): now $0.07875 per share quarterly dividend, was $0.0750. Artisan Partners Asset Management (APAM): Now $0.65 per share quarterly dividend, was $0.61. BankFirst Capital (BFCC): now $0.90 per share dividend, was $0.85. Berry Global Group … Read more

US Congress Is Getting Ready to Pass a Massive ~$2.2 Trillion Fiscal Stimulus Bill

by

Image Shown: US equities have started to recover some of their lost ground as the likelihood that the US Congress will pass a massive ~$2.2 trillion fiscal stimulus and emergency spending package, dubbed the CARES Act, has increased significantly over the past week as seen through the bounce in the SPDR S&P 500 ETF Trust (SPY). President Trump has clearly indicated that he intends to sign such a bill into law as soon as possible, with the US House of Representatives expected to take up the legislation this upcoming Friday morning on March 27. By Callum Turcan On March 25, the US Senate worked late into the night to secure a bipartisan compromise on a massive ~$2.2 trillion fiscal stimulus … Read more

Our Thoughts on Big Pharma’s Calendar Fourth Quarter Earnings Reports

by

Image Source: Merck & Company Inc – Fourth Quarter of 2021 IR Earnings Presentation By Callum Turcan In Alphabetical Order by Ticker: ABBV, GILD, LLY, MRK We include the Health Care Select Sector SPDR Fund ETF (XLV) in the Best Ideas Newsletter and Dividend Growth Newsletter portfolios to gain broad exposure to the health care sector. Instead of betting on one entity’s pipeline (which could be hit or miss), we like the exposure to lots and lots of “shots on goal” when it comes to the vast collective pipeline in the XLV ETF. We wrote up the calendar fourth-quarter results of the top two weightings in the XLV ETF, United Health (UNH) and Johnson & Johnson (JNJ) here and here, … Read more

Dividend Increases/Decreases for the Week Ending November 18

by

Below we provide a list of firms that raised/lowered their dividends during the week ending November 18. The dividend reports of covered firms on this list will be updated shortly with the new information. To access our dividend reports use the ‘Symbol’ search box in our website header. Firms Raising Their Dividends This Week Agilent Technologies (A): now $0.132 per share quarterly dividend, was $0.115. American Equity (AEL): now $0.24 per share annual dividend, was $0.22. Assurant (AIZ): now $0.53 per share quarterly dividend, was $0.50. Bancroft Fund (BCV): now $0.52 per share quarterly dividend, was $0.25. Brown-Forman (BF.A): now $0.1825 per share quarterly dividend, was $0.17. Brunswick (BC): now $0.165 per share quarterly dividend, was $0.15. C&F Financial (CFFI): … Read more

Vodafone’s Dividend Cut, Alibaba’s Resilience, More Reports

by

Vodafone’s Dividend Cut, Alibaba’s Resilience, More Reports In alphabetical order by company name: A, BABA, PLCE, GES, M, NSANY, RL, TLRY, VOD — Good morning, — Still buying stocks immediately as they fall and on the way down? There may be no logical basis for doing so. Here’s an excerpt from Value Trap: Theory of Universal Valuation.  — Image: Excerpt from Value Trap, page 241 — Order your copy here.  — The market must eventually agree with you for your idea to work out, so why not wait until the stock starts to move higher first. Waiting a few weeks or a few months/quarters to see if the stock eventually settles and technical/momentum indicators start to improve is vital in helping … Read more